Vaccines as an Effective Treatment for Triple-Negative Breast Cancer

Breast cancer is a malignant tumor that originates from the breast tissue. Triple-negative breast cancer (TNBC) accounts for a certain proportion of all types of breast cancer, and it is a type of breast cancer that is difficult to treat and highly dangerous. Triple-negative breast cancer (TNBC) lacks three receptors, which leads to its difficulty in treatment. The common treatment methods for triple-negative breast cancer (TNBC) mainly include chemotherapy and immunotherapy. Immunotherapy is a treatment approach that targets the tumor's ability to evade the immune system's attack, helping T cells maintain normal activity and stimulating the immune response. Although chemotherapy leads to a relatively good prognosis, it poses significant harm to the human body. In recent years, there have been many advancements in the use of vaccines for treating triple-negative breast cancer (TNBC). This review article will mainly discuss the current progress, advantages, and challenges of using vaccines to treat triple-negative breast cancer (TNBC).